SHORT-TERM TREATMENT OF IDIOPATHIC PRECOCIOUS PUBERTY WITH A LONG-ACTING ANALOG OF LUTEINIZING-HORMONE-RELEASING HORMONE - A PRELIMINARY-REPORT
SHORT-TERM TREATMENT OF IDIOPATHIC PRECOCIOUS PUBERTY WITH A LONG-ACTING ANALOG OF LUTEINIZING-HORMONE-RELEASING HORMONE - A PRELIMINARY-REPORT
复制标题
DOI:
10.1056/nejm198112243052602
复制
发表时间:
1981-01-01
影响因子:
158.5
通讯作者:
CROWLEY, WF
中科院分区:
文献类型:
--
作者:
COMITE, F;CUTLER, GB;CROWLEY, WF
The uncoupling of pituitary stimulation and response observed in adults during administration of the LHRH analog, D-Trp6-Pro9-NEt-LHRH (LHRHa) suggested that this drug might be useful in treating precocious puberty. Five girls with idiopathic precocious puberty (ages 2-8 yr) were treated for 8 wk with daily s.c. injections of LHRHa. The patients had Tanner II-IV pubertal development, advanced bone age, an estrogen effect on vaginal smear, measurable basal gonadotropin levels with pulsed nocturnal secretion and a pubertal gonadotropin response to LHRH. Irregular vaginal bleeding was present in 3 patients. LHRHa significantly decreased basal (P < 0.025) and LHRH-stimulated (P < 0.01) gonadotropin levels and serum estradiol (P < 0.05). The vaginal maturation-index score, which reflects the estrogen effect, fell by 25%. Eight weeks after stopping treatment, all hormonal values and the vaginal maturation index had returned to pretreatment levels. These favorable short-term results will need further study before the benefits and risks of chronic treatment with LHRHa can be adequately assessed.